Israel’s Immunai expands strategic tie with AstraZeneca
Israeli firm Immunai, a developer of AI-based instruments for enhancing drug discovery processes, has introduced a strategic settlement with ...
Israeli firm Immunai, a developer of AI-based instruments for enhancing drug discovery processes, has introduced a strategic settlement with ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.